US Patent 11110095 Pyrimidine compounds as JAK kinase inhibitors
Patent 11110095 was granted and assigned to Theravance on September, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11110095 Pyrimidine compounds as JAK kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
